Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Total Liabilities

Latest as of September 2025: CN¥1.98 Billion CNY ≈ $289.84 Million USD

Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) has total liabilities worth CN¥1.98 Billion CNY (≈ $289.84 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Yunnan Botanee Bio-Technology Group Co L cash flow conversion to assess how effectively this company generates cash.

Yunnan Botanee Bio-Technology Group Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 300957 financial resilience to evaluate the company's liquid asset resilience ratio.

Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Yunnan Botanee Bio-Technology Group Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Hinge Health, Inc.
NYSE:HNGE
USA $366.23 Million
Watsco Inc
NYSE:WSO-B
USA $1.25 Billion
Celldex Therapeutics Inc
NASDAQ:CLDX
USA $55.82 Million
Orion Oyj A
HE:ORNAV
Finland €726.20 Million
ZhongAn Online P & C Insurance Co. Ltd
F:1ZO
Germany €21.89 Billion
China Railway Hi-tech Industry Corp Ltd
SHG:600528
China CN¥39.09 Billion
Zhongshan Public Utilities Group Co Ltd
SHE:000685
China CN¥17.17 Billion
Gujarat Mineral Development Corporation Limited
NSE:GMDCLTD
India Rs15.47 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Yunnan Botanee Bio-Technology Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yunnan Botanee Bio-Technology Group Co L stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.64 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.33 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.24 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yunnan Botanee Bio-Technology Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2024)

The table below shows the annual total liabilities of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥2.12 Billion
≈ $309.60 Million
+41.89%
2023-12-31 CN¥1.49 Billion
≈ $218.20 Million
+33.50%
2022-12-31 CN¥1.12 Billion
≈ $163.44 Million
+8.02%
2021-12-31 CN¥1.03 Billion
≈ $151.31 Million
+158.47%
2020-12-31 CN¥400.05 Million
≈ $58.54 Million
+23.92%
2019-12-31 CN¥322.82 Million
≈ $47.24 Million
+3.10%
2018-12-31 CN¥313.11 Million
≈ $45.82 Million
+30.79%
2017-12-31 CN¥239.40 Million
≈ $35.03 Million
--

About Yunnan Botanee Bio-Technology Group Co Ltd

SHE:300957 China Household & Personal Products
Market Cap
$2.53 Billion
CN¥17.32 Billion CNY
Market Cap Rank
#5449 Global
#1100 in China
Share Price
CN¥40.88
Change (1 day)
-1.04%
52-Week Range
CN¥36.21 - CN¥50.85
All Time High
CN¥277.86
About

Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. The company operates through Skin Care Products and Medical Instruments segments. It offers face creams, lotions, masks, and essences and lotions; and makeup products, including primers, powders, BB creams, and makeup rem… Read more